Helping lung cancer patients decide about genetic testing
Part of Cancer clinical trials.
This study tests a shared decision-making approach to help people with lung adenocarcinoma decide whether to get molecular (genetic) testing. It aims to improve understanding and support better choices about testing and possible targeted treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have lung cancer that is adenocarcinoma diagnosed by a sample taken during surgery (frozen section)
- You either already decided to get lung genetic/molecular testing, or you have not decided yet
- You are able to understand the study information
- If you are staff (nurse/doctor/other decision-maker), you have relevant experience (at least 2 years) and appropriate communication training/knowledge
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at inherited genetic changes in people with a type of lung cancer called lung adenocarcinoma. The goal is to find gene variants linked to the disease, which may help guide future treatment decisions.
This study helps patients with lung nodules that might be cancer make informed choices about their next steps—whether to have surgery, more tests, or watch and wait. Researchers will gather information about how patients and doctors make these decisions together.
This study looks at what doctors and patients consider when deciding on a first-line treatment for advanced lung cancer. It aims to understand how choices are made for people taking a type of targeted therapy.
This study looks at genetic changes in people with suspected or high-risk lung cancer. It aims to use those results to guide more personalized treatment decisions.
This trial tests a quality-of-life support program meant to help people with early-stage lung cancer think through their treatment choices. It may help you feel more informed and more confident about deciding between treatments like surgery and SBRT.
This study collects and analyzes lung cancer tissue samples to understand genetic differences that may help guide future treatment. You'll provide a tissue sample (either from a biopsy or prior surgery), and researchers will study it—no treatment is given in this study.
Hear when a new Surgery trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.